First Time Loading...
T

Techno Medica Co Ltd
TSE:6678

Watchlist Manager
Techno Medica Co Ltd
TSE:6678
Watchlist
Price: 1 724 JPY -0.06% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

17.4B
+12%
Assets
Growth Rates:
1 Year
-10%
3 Years
-1%
5 Years
+8%
7 Years
+24%
10 Years
+26%
3.6B
+55%
Liabilities
Growth Rates:
1 Year
+18%
3 Years
+39%
5 Years
+50%
7 Years
+86%
10 Years
+34%
13.8B
+4%
Equity
Growth Rates:
1 Year
-16%
3 Years
-8%
5 Years
+1%
7 Years
+14%
10 Years
+24%

Balance Sheet Decomposition
Techno Medica Co Ltd

17.4B
Assets
3.6B
Liabilities
17.4B
Assets
3.6B
Liabilities
Current Assets 15.1B
Cash & Short-Term Investments 8.6B
Receivables 4.3B
Other Current Assets 2.2B
Non-Current Assets 2.4B
Long-Term Investments 7.5m
PP&E 1.4B
Intangibles 71.3m
Other Non-Current Assets 825m
Current Liabilities 3.4B
Accounts Payable 1.4B
Accrued Liabilities 422.8m
Other Current Liabilities 1.5B
Non-Current Liabilities 255.9m
Other Non-Current Liabilities 255.9m

Balance Sheet
Techno Medica Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
7 540
7 959
8 239
9 327
9 519
9 762
10 139
11 524
11 750
8 586
Cash Equivalents
7 540
7 959
8 239
9 327
9 519
9 762
10 139
11 524
11 750
8 586
Total Receivables
3 420
3 223
2 742
3 220
3 229
3 320
3 606
3 652
3 658
4 297
Accounts Receivables
2 725
2 236
2 301
3 030
3 171
3 270
3 519
3 621
3 534
4 241
Other Receivables
694
986
442
189
58
50
87
31
124
56
Inventory
2 454
2 006
1 484
1 196
1 596
1 359
1 646
1 229
1 866
2 155
Other Current Assets
114
154
145
40
43
70
80
68
33
43
Total Current Assets
13 528
13 342
12 610
13 783
14 387
14 512
15 471
16 473
17 307
15 081
PP&E Net
1 356
1 292
1 265
1 256
1 268
1 605
1 564
1 492
1 528
1 449
PP&E Gross
1 356
1 292
1 265
1 256
1 268
1 605
1 564
1 492
1 528
1 449
Accumulated Depreciation
588
654
717
779
838
921
1 032
1 139
1 204
1 289
Intangible Assets
31
22
23
19
35
29
24
33
23
71
Long-Term Investments
8
8
8
8
8
8
8
8
8
8
Other Long-Term Assets
226
138
211
427
458
416
488
502
578
825
Total Assets
15 148
N/A
14 801
-2%
14 116
-5%
15 493
+10%
16 155
+4%
16 570
+3%
17 554
+6%
18 508
+5%
19 443
+5%
17 434
-10%
Liabilities
Accounts Payable
2 176
1 574
705
1 233
1 112
1 082
1 135
1 283
1 500
1 415
Accrued Liabilities
377
194
150
285
226
342
321
408
274
423
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
709
730
744
662
805
804
928
939
1 037
1 521
Total Current Liabilities
3 262
2 499
1 599
2 181
2 144
2 227
2 384
2 630
2 810
3 359
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
308
221
347
294
270
194
210
228
246
256
Total Liabilities
3 570
N/A
2 720
-24%
1 947
-28%
2 475
+27%
2 413
-3%
2 421
+0%
2 594
+7%
2 858
+10%
3 056
+7%
3 615
+18%
Equity
Common Stock
1 070
1 070
1 070
1 070
1 070
1 070
1 070
1 070
1 070
1 070
Retained Earnings
9 541
10 361
10 449
11 383
12 095
12 693
13 416
14 261
14 891
15 731
Additional Paid In Capital
968
968
968
968
968
968
968
968
968
1 003
Treasury Stock
0
0
318
403
391
581
494
649
542
3 985
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
11 578
N/A
12 081
+4%
12 169
+1%
13 018
+7%
13 742
+6%
14 149
+3%
14 960
+6%
15 650
+5%
16 387
+5%
13 819
-16%
Total Liabilities & Equity
15 148
N/A
14 801
-2%
14 116
-5%
15 493
+10%
16 155
+4%
16 570
+3%
17 554
+6%
18 508
+5%
19 443
+5%
17 434
-10%
Shares Outstanding
Common Shares Outstanding
9
9
9
9
9
8
9
8
8
7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.